Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL29016324 | 0.98 | ALDH1A1 (0.49) | ALDH1A1TDP1PTGS2RAD52SLC18A3 | |
| SCHEMBL887521 | 0.95 | ALDH1A1 (0.49) | ALDH1A1TDP1PTGS2RAD52SLC18A3 | |
| SCHEMBL3794162 | 0.93 | ALDH1A1 (0.47) | ALDH1A1TDP1PTGS2RAD52SLC18A3 | |
| SCHEMBL27649890 | 0.89 | ALDH1A1 (0.48) | ALDH1A1TDP1PTGS2RAD52SLC18A3 | |
| SCHEMBL13766083 | 0.80 | TDP1 (0.55) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| SCHEMBL25490098 | 0.79 | TDP1 (0.45) | ALDH1A1TDP1TSHRL3MBTL1MAPK1 | |
| SCHEMBL7590667 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TDP1PTGS2SLC18A3TSHR | |
| SCHEMBL27813818 | 0.77 | LMNA (0.54) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| SCHEMBL15132441 | 0.77 | ALDH1A1 (0.47) | ALDH1A1TDP1L3MBTL1LMNA | |
| SCHEMBL18570037 | 0.76 | MAPK1 (0.40) | ALDH1A1TDP1TSHRL3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115466232-B | Preparation method of (6Z, 9Z) -3, 4-epoxy nineteen-carbon diene | 山西农业大学 | 2023-06-20 | — | — | CN | disclosed |
| CN-115466232-A | Preparation method of (6Z, 9Z) -3, 4-epoxy nonadecadiene | 山西农业大学 | 2022-12-13 | — | — | CN | disclosed |
| US-8129552-B2 | for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20080214849-A1 | PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSHAFTEN E.V. (DE) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214849-A1 | PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | PHOSPHO1, PLTP, SGMS1 | ALDH1A1 4394/4885TDP1 2874/4885PTGS2 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.